Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Global Cancer Research Institute is a community-based hematology and oncology practice and clinical trial unit based in Northern California. The organization operates as a dedicated Phase 1 to 4 oncology research and care site, offering patients access to investigational cancer therapies, standard oncology care, infusion services, tumor banking, and genetic testing. GCRI appears to function primarily as a clinical research provider and specialty cancer care organization rather than a therapeutic product developer with a proprietary drug pipeline. Its sponsor-facing capabilities include clinical operations, patient enrollment, specimen collection, and electronic data capture integrated with its medical records workflow. The company collaborates with community physicians, hospitals, and biopharma sponsors to run oncology studies in both solid tumors and hematologic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Global Cancer Research Institute.